Baylor Scott & White Research Institute facilitates rewarding networks between our innovators and partner companies
This network of resources and expertise culminate in a system that delivers research innovation across 50 specialties areas and nearly 2,000 active trials each year, resulting in hundreds of publications.
Our dedicated technology transfer service also helps to evaluate, patent, market and license technology developed through BSWRI by our researchers and inventors, as well as through collaborations with third-party companies, investors and entrepreneurs, as well as collegial alliances.
We have commercialized pioneering discoveries, including patents that have led to treatments for systemic onset juvenile idiopathic arthritis, lysosomal storage disorders and cancer therapies.
Additional licensable patented technologies are available in areas such as:
- Immunotherapies
- Vaccines
- Biomarkers for heart failure, colorectal cancer and other conditions
- Targeting antibodies
- Medical devices (implanted and external assist devices)